HMS-014 - The hidden side of COVID-19: How much we have contributed to the spread of C. difficile infection through treatment?

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: HMS-014
• By: KONDžA, Martin (University Of Mostar Faculty Of Pharmacy / Pharmaceutical Chamber of the Federation of Bosnia and Herzegovina, Bosnia and Herzegovina)
• Co-author(s): Dr Martin Kondža (University Of Mostar Faculty Of Pharmacy / Pharmaceutical Chamber of the Federation of Bosnia and Herzegovina, Mostar, Bosnia and Herzegovina)
  MPharm Ivana Matić (University Of Mostar Faculty Of Pharmacy / Pharmaceutical Chamber of the Federation of Bosnia and Herzegovina, Mostar, Bosnia and Herzegovina)
  Dr Ivona Ivančić (University Of Mostar Faculty Of Pharmacy / Pharmaceutical Chamber of the Federation of Bosnia and Herzegovina, Mostar, Bosnia and Herzegovina)
  
• Abstract:

  Introduction: The COVID-19 pandemic has significantly impacted healthcare systems worldwide, leading to changes in treatment protocols, prolonged hospital stays, and increased use of broad-spectrum antibiotics. Clostridioides difficile infection (CDI) remains a major healthcare-associated infection, often linked to antibiotic overuse. This study..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login